Cargando…

Rituximab-induced interstitial lung disease in a patient with follicular lymphoma: A rare case report

Rituximab is a chimeric monoclonal antibody that targets CD-20 antigen expressed in more than 90% of all B cell non-Hodgkin's lymphoma (NHL). We report a case of 33-year-old female without any comorbidities, newly diagnosed with stage IIIB follicular lymphoma treated with rituximab-based chemot...

Descripción completa

Detalles Bibliográficos
Autores principales: Aagre, Suhas, Patel, Apurva, Kendre, Pradip, Anand, Asha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663870/
https://www.ncbi.nlm.nih.gov/pubmed/26664173
http://dx.doi.org/10.4103/0970-2113.168135

Ejemplares similares